On July 16, HubSpot rose 5.05% in regular trading, trading at 226.0 USD/share, with turnover of $86.09 million.
On the news front, the application software sector strengthened broadly, while an Oppenheimer research note continued to provide upside catalyst. The firm noted that HubSpot saw stronger-than-expected Q2 demand, driven by improving sales momentum, larger deal sizes, and growing AI adoption, offering fundamental support for the stock's recovery.
HubSpot had suffered a 24% single-day plunge in early May after announcing a shift to an AI agent-first go-to-market strategy coupled with Q2 revenue guidance that fell below expectations. The stock was subsequently downgraded by Bank of America, Macquarie, and BNP Paribas, among others. BofA cut its rating to underperform with a $180 price target, citing significant execution risk from simultaneous changes in pricing, packaging, and sales focus. The stock remains in a low-level recovery phase, with sector-wide fund inflows and research catalysts sustaining the rebound momentum.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments